Sector Gamma AS’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4M Sell
68,000
-12,000
-15% -$733K 0.83% 36
2026
Q2
$4.54M Buy
+80,000
New +$3.55M 0.99% 33

Other funds holding TVTX

Sector Gamma AS's TVTX Position: Q3 2026 in Review

Sector Gamma AS reduced its Travere Therapeutics (TVTX) stake by 15% in Q3 2026, selling an estimated $733K and leaving 68,000 shares worth $4M. The position accounts for 0.83% of the portfolio, ranked #36.

Sector Gamma AS first reported a position in TVTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $4.54M in Q2 2026. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • Sector Gamma AS held 68,000 shares of Travere Therapeutics worth $4M as of Q3 2026.
  • Sector Gamma AS sold 12,000 Travere Therapeutics shares in Q3 2026, an estimated $733K.
  • Travere Therapeutics made up 0.83% of Sector Gamma AS's portfolio in Q3 2026, its #36 holding.
  • Sector Gamma AS first reported a position in Travere Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Sector Gamma AS's Travere Therapeutics position peaked at $4.54M in Q2 2026.
  • 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on Sector Gamma AS's 13F filing for Q3 2026, filed 12 Nov 2026.